Evidence-informed guidelines for treating frail older adults with type 2 diabetes: From the diabetes care program of nova scotia (DCPNS) and the palliative and therapeutic harmonization (PATH) program

Journal of the American Medical Directors Association

Volumn 14, Issue 11, 2013, Pages 801-808

  Mallery, Laurie Herzig ^a   Ransom, Tom ^a   Steeves, Brian ^b   Cook, Brenda ^c   Dunbar, Peggy ^c   Moorhouse, Paige ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b VP Community Health   (Canada)

^c Diabetes Care Program of Nova Scotia   (Canada)

Author keywords

Clinical practice guidelines; Diabetes; Frailty; Glycosylated hemoglobin (HbA1c); Random blood glucose

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN;

ADULT; CANADA; FRAILTY; GERIATRIC CARE; HEALTH PROGRAM; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PALLIATIVE THERAPY; PHYSICAL DISEASE; PRACTICE GUIDELINE; REVIEW;

CLINICAL PRACTICE GUIDELINES; DIABETES; FRAILTY; GLYCOSYLATED HEMOGLOBIN (HBA1C); RANDOM BLOOD GLUCOSE;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; FRAIL ELDERLY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; NOVA SCOTIA; PALLIATIVE CARE;

EID: 84886776631     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.08.002     Document Type: Review

References (78)

1. Boyd C.M., Darer J., Boult C., et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005, 294:716-724.
2. Van Spall H.G., Toren A., Kiss A., et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007, 297:1233-1240.
3. Holmes H.M., Hayley D.C., Alexander G.C., et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006, 166:605-609.
4. Field T.S., Gurwitz H., Avorn J., et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001, 161:1629-1634.
5. Hubbard R.E., Andrew M.K., Fallah N., et al. Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diabet Med 2010, 27:603-606.
6. Tinetti M.E., Bogardus S.T., Agostini J.V. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. NEngl J Med 2004, 351:2870.
7. Diabetes Care Program of Nova Scotia. Targets for glycemic control. Available at: Accessed September 6, 2013. http://diabetescare.nshealth.ca/sites/default/files/files/LTCPocketReference.pdf.
8. Moorhouse P., Mallery L. Palliative and therapeutic harmonization: A model for appropriate decision-making in frail older adults. JAm Geriatr Soc 2012, 60:2326-2332.
9. Palliative and Harmonization Clinic. Home page. Available at: Accessed September 6, 2013. http://www.pathclinic.ca.
10. Mallery L.H., Moorhouse P. Respecting frailty. JMed Ethics 2011, 37:126-128.
11. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
12. Searle S.D., Mitnitski A., Gahbauer E.A., et al. Astandard procedure for creating a frailty index. BMC Geriatr 2008, 8:24.
13. Theou O., Rockwood K. Should frailty status always be considered when treating the elderly patient?. Aging Health 2012, 8:261-271.
14. Gill T.M., Gahbauer E.A., Han L., et al. Trajectories of disability in the last year of life. NEngl J Med 2010, 362:1173-1180.
15. Robinson T.N., Wu D.S., Stiegmann G.V., et al. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg 2011, 202:511-514.
16. Makary M.A., Segev D.L., Pronovost P.J., et al. Frailty as a predictor of surgical outcomes in older patients. JAm Coll Surg 2010, 210:901-908.
17. Murray A.M., Knopman D.S. Cognitive impairment in CKD: No longer an occult burden. Am J Kidney Dis 2010, 56:615-618.
18. Ekerstad N., Swahn E., Janzon M., et al. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 2011, 124:2397-2404.
19. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: Evidence for a phenotype. JGerontol A Biol Sci Med Sci 2001, 56:M146-M156.
20. Morley J.E., Malmstrom T.K., Miller D.K. Asimple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. JNutr Health Aging 2012, 16:601-608.
21. Woo J., Leung J., Morley J.E. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. JAm Geriatr Soc 2012, 60:1478-1486.
22. Abellan van Kan G., Rolland Y., Bergman H., et al. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. JNutr Health Aging 2008, 12:29-37.
23. Morley J.E., Abbatecola A.M., Argiles J.M., et al. Sarcopenia with limited mobility: An international consensus. JAm Med Dir Assoc 2011, 12:403-409.
24. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. JAm Med Dir Assoc 2011, 12:249-256.
25. Leenders M., Verdijk L.B., van der Hoeven L., et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. JAm Med Dir Assoc 2013, 14:585-592.
26. Rockwood K., Song X., MacKnight C., et al. Aglobal clinical measure of fitness and frailty in elderly people. CMAJ 2005, 173:489-495.
27. Diabetes Care Program of Nova Scotia. Home page. Available at: Accessed September 6, 2013. http://diabetescare.nshealth.ca.
28. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group, Erratum in Lancet 1999;354(9178):602.
29. ADVANCE Collaborative Group, Patel A., MacMahon S., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. NEngl J Med 2008, 358:2560-2572.
30. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., et al. Effects of intensive glucose lowering in type 2 diabetes. NEngl J Med 2008, 358:2545-2559.
31. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. VDAT Study. NEngl J Med 2009, 360(2):129-139. Erratum in N Engl J Med 2009;361:1028; N Engl J Med 2009;361:1024-1025.
32. Holman R.R., Paul S.K., Bethel M.A., et al. 10-year follow-up of intensive glucose control in type 2 diabetes. NEngl J Med 2008, 359:1577-1589.
33. Bruno G., Biggeri A., Merletti F., et al. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: A 10-year prospective study. Diabetes Care 2003, 26:2353-2358.
34. Ray K.K., Seshasai S.R., Wijesuriya S., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet 2009, 373:1765-1772.
35. Group Control, Turnbull F.M., Abraira C., et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009, 52:2288-2298. Erratum in Diabetologia 2009;52:2470. Control Group [added].
36. Hemmingsen B., Lund S.S., Gluud C., et al. Intensive glycemic control for patients with type 2 diabetes: Systematic review with meta-analysis and trial sequential analysis of randomized clinical trials. BMJ 2011, 343:d6898.
37. Coca S.G., Ismail-Bergi F., Haq N., et al. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: Systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med 2012, 172:761-769. Erratum in Arch Intern Med 2012;172:1095.
38. Montori V.M., Ferández-Balsells M. Glycemic control in type 2 diabetes: Time for an evidence-based about-face?. Ann Intern Med 2009, 150:803-808. Erratum in Ann Intern Med 2009:151:144.
39. Nathan D.M., Buse J.B., Davidson M.B., et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009, 52:17-30.
40. Inzucchi S.E., Bergenstal R.M., Buse J.B., et al. Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35:1364-1379.
41. Qaseem A., Vijan S., Snow V., et al. Glycemic control and type 2 diabetes mellitus: The optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 2007, 147:417-422.
42. Brown A.F., Mangione C.M., Saliba D., et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. JAm Geriatr Soc 2003, 51:S265-S280.
43. Canadian Diabetes Association. Clinical practice guidelines. Available at: Accessed September 6, 2013. http://guidelines.diabetes.ca.
44. VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus. Version 4.0 2010, Management of Diabetes Mellitus Update Working Group, Veterans Health Administration and Department of Defense, Washington, DC.
45. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
46. Kirkman S.M., Briscoe V.J., Clark N., et al. Diabetes in older adults: A consensus report. JAm Geriatr Soc 2012, 60:2342-2356.
47. Aron D., Conlin P.R., Hobbs C., et al. Individualizing glycemia targets in type 2 diabetes mellitus. Ann Intern Med 2011, 155:340-341.
48. Lee S.J., Boscardin W.J., Stijacic Cenzer I., et al. The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus. JAm Geriatr Soc 2011, 59:666-672.
49. Lee S.J., Eng C. Goals of glycemic control in frail older patients with diabetes. JAMA 2011, 305:1350-1351.
50. McCulloch D.K., Munshi M. Treatment of type 2 diabetes mellitus in the elderly patients 2012, UpToDate, Waltham, MA. D.S. Basow (Ed.).
51. McCulloch D.K., Nathan D.M., Mulder J.E. Glycemic control and vascular complications in type 2 diabetes mellitus 2012, UpToDate, Waltham, MA. D.S. Basow (Ed.).
52. Cayea D., Boyd C., Durso S.C. Individualising therapy for older adults with diabetes mellitus. Drugs Aging 2007, 24:851-863.
53. Brouwers M., Kho M.E., Browman G.P., et al. for the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. CMAJ 2010, 182:E839-E842.
54. Hoelzel W., Weykamp C., Jeppsson J.O., et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clin Chem 2004, 50:166-174.
55. Meneilly G.S., Cheung E., Tuokko H. Altered responses to hypoglycemia of healthy elderly people. JClin Endocrinol Metab 1994, 78:1341-1348.
56. Yaffe K., Falvey C.M., Hamilton N., et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013, 173:1300-1306.
57. Yau C.K., Eng C., Cenzer I.S., et al. Glycosylated hemoglobin and functional decline in community-dwelling nursing home-eligible elderly adults with diabetes mellitus. JAm Geriatr Soc 2012, 60:1215-1221.
58. Weinberger M., Kirman M.S., Samsa G.P., et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 1994, 32:1173-1181.
59. Ahroni J.H., Boyko E.J., Davignon D.R., et al. The health and functional status of veterans with diabetes. Diabetes Care 1994, 17:318-321.
60. Testa M.A., Simonson D.C., Tuner R.R. Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care 1998, 21:C44-C52.
61. Lau C.Y., Qureshi A.K., Scott S.G. Association between glycemic control and quality of life in diabetes mellitus. JPostgrad Med 2004, 50:189-193.
62. Nelson J.M., Dufraux K., Cook P.F. The relationship between glycemic control and falls in older adults. JAm Geriatr Soc 2007, 55:2041-2044.
63. Schwartz A.V., Vittinghoff E., Sellmeyer D.E., et al. Diabetes related complications, glycemic control and falls in older adults. Diabetes Care 2008, 31:391-396. Erratum in Diabetes Care 2008;31:1089.
64. Wang C.P., Hazuda H.P. Better glycemic control is associated with maintenance of lower-extremity function over time in Mexican American and European American older adults with diabetes. Diabetes Care 2011, 34:368-373.
65. Huang E.S., Liu J.Y., Moffet H.H., et al. Glycemic control, complications, and death in older diabetic patients: The diabetes and aging study. Diabetes Care 2011, 34:1329-1336.
66. Mooradian A.D., Osterweil D., Petrasek D., et al. Diabetes mellitus in elderly nursing home patients. A survey of clinical characteristics and management. JAm Geriatr Soc 1998, 36:391-396.
67. Hauner H., Kurnaz A.A., Haastert B., et al. Undiagnosed diabetes mellitus and metabolic control assessed by HbA(1c) among residents of nursing homes. Exp Clin Endocrinol Diabetes 2001, 109:326-329.
68. McCulloch D.K. Blood glucose self-monitoring in management of adults with diabetes mellitus 2012, UpToDate, Waltham, MA. D.S. Basow (Ed.).
69. Malanda U.L., Welschen L.M.C., Riphagen, et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev 2012, 1:CD005060.
70. Resnick H.E., Heineman J., Stone R., et al. Diabetes in US nursing homes, 2004. Diabetes Care 2008, 31:287-288.
71. Diabetes Care Program of Nova Scotia. Department of Health and Wellness SEAscape Database, June2011.
72. Rockwood K., Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011, 27:17-26.
73. Nathan D.M., Kuenan J., Borg R., et al. Translating the A1C assay into estimated average glucose values. A1c-Derived Average Glucose Study Group. Diabetes Care 2008, 31:1473-1478. Erratum in Diabetes Care 2009;32:207.
74. Donner T., Muñoz M. Update on insulin therapy for type 2 diabetes. JClin Endocrinol Metab 2012, 97:1405-1413.
75. Long-acting insulin analogues for the treatment of diabetes mellitus: Meta-analyses of clinical outcomes. CADTH Technol Overv 2010, 1(1):e0113. Canadian Agency for Drugs and Technologies in Health (CADTH).
76. CADTH. Second- and third-line therapy for patients with type 2 diabetes. Available at: Accessed September 6, 2013. http://www.cadth.ca/en/products/optimal-use/second-line-therapies.
77. Coulson A.M., Mandelbaum D., Reaven G.M. Dietary management of nursing home residents with non-insulin dependent diabetes mellitus. Am J Clin Nutr 1990, 51:67-71.
78. Ko F.C. The clinical care of frail, older adults. Clin Geriatr Med 2011, 27:89-100.